North America Analysis
Home Search

Public Safety - search results

If you're not happy with the results, please do another search
late blight disease, genetic

Defeating late blight disease of potato in sub-Saharan Africa

Three academic experts, including Richard E. Goodman from the Food Allergy Research and Resource Program, shed light on defeating late blight disease of potato in sub-Saharan Africa, starting with a brief introduction to the crop in question.
700,000 astrazeneca, australia

Over 700,000 AstraZeneca doses sent from UK to Australia

Today (8 April) it was revealed that over 700,000 AstraZeneca doses manufactured in the UK are being sent to Australia - with a confirmed 300,000 vaccines in Sydney at the end of February.
sustainable mobility

Smart and sustainable mobility for the future

Open Access Government explores Europe’s current smart mobility priorities, learning why Intelligent Transport Solutions (ITS) are key to advancing the transport sector in a sustainable and innovative way.
natural sciences

Driving natural sciences and engineering research in Canada

Open Access Government discusses the importance of funding visionaries, explorers and innovators who are searching for scientific and technical breakthroughs in Canada.
healthier european union

A vision for a healthier European Union

Open Access Government explores the health priorities of Stella Kyriakides, Commissioner for Health and Food Safety, asking if lessons learned from the ongoing COVID-19 pandemic can help to improve European healthcare?.
help the nhs

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.
uv-c cleaning

UV-C disinfection could be the solution to a COVID-safe return to school

Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.
business rates

Business rates and empty properties

Here, the team at SafeSite Security Solutions talk about Empty Property Rates and the recent decision by the Court of Appeal to dismiss a public interest challenge to a Government scheme for the mitigation of business rates on empty property.
cybersecurity protections

Smart cities are only as smart as their cybersecurity protections

Adrian Crawley, VP of Synack’s EMEA region, looks at the challenges ‘green’ measures place on cybersecurity protections, vehicle safety, data, city planning, personal information and payments and how a collaborative approach is needed to overcome them.
vaccines for uk, astrazeneca vaccine

AstraZeneca vaccines made for UK could be kept for EU use only

EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.
psychiatric disorders

The changing perspective of psychedelic drugs with a history of abuse

Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
clean air zones

Clean Air Zones post-pandemic

Stephen O’Sullivan, Head of Enforcement Business Development and Sales at Siemens Mobility, discusses how the pandemic has affected plans for Clean Air Zones (CAZs).
Marian Schaapman

Marian Schaapman – European Trade Union Institute (ETUI)

Marian Schaapman has been Head of the Health & Safety and Working Conditions Unit, Research Department, European Trade Union Institute (ETUI) since October 2017.
astrazeneca vaccine unsafe, vaccine

Poll finds 61% of people in France think AstraZeneca vaccine is unsafe

According to a new YouGov poll, 61% of people in France now believe that the AstraZeneca vaccine is unsafe, with Germany following closely at 55% - creating fears about the potential impact of vaccine hesitancy on the rollout.
gene-edited crops

Gene-edited crops are not GMOs 2.0

David Green, Executive Director at U.S. Sustainability Alliance and a commentator and advisor on food and agriculture for GreenOrange, argues that gene-edited crops are not GMOs 2.0.
cause blood clots, astrazeneca vaccine

European Medicines Agency say AstraZeneca does not cause blood clots

The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".
e-scooters

Accelerating the UK’s emergence from the pandemic with e-scooters

Noa Khamallah, former Executive at Voi and Lime, argues that not only are e-scooters the perfect fit for the cities of the future but they can also help speed up the UK's emergence from the pandemic.
building technology

What’s the ‘next normal’ for our building technology?

Siemens provides a perspective on being smarter, safer and more connected when it comes to what’s the ‘next normal’ for our building technology, including comment on energy consumption.
meat processing industry

A zero-waste approach in the meat processing industry

BETA Technological Center explains its experience on the valorisation of organic wastes from the meat processing industry to obtain biostimulants.
risk of blood clots, astrazeneca vaccine

Birth control creates higher risk of blood clots than AstraZeneca vaccine

Currently, several EU countries are suspending use of the AstraZeneca vaccine due to reports of blood clot risks - in response, people are speaking out about the higher risk of blood clots posed by contraceptive pills used globally.

Follow Open Access Government